文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

新型冠状病毒肺炎与心脏

COVID-19 and the Heart.

机构信息

From the Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

出版信息

Circ Res. 2020 May 8;126(10):1443-1455. doi: 10.1161/CIRCRESAHA.120.317055. Epub 2020 Apr 7.


DOI:10.1161/CIRCRESAHA.120.317055
PMID:32252591
Abstract

Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 is a systemic illness characterized by hyperinflammation, cytokine storm, and elevations of cardiac injury biomarkers. Here, we review what is known about the pathophysiology of COVID-19, its cardiovascular manifestations, and emerging therapeutic prospects. In this rapidly moving field, this review was comprehensive as of April 3, 2020.

摘要

感染严重急性呼吸综合征新型冠状病毒会产生一种被称为 2019 年新型冠状病毒病(COVID-19)的临床综合征。当病情严重时,COVID-19 是一种全身性疾病,其特征是过度炎症、细胞因子风暴以及心肌损伤生物标志物升高。在这里,我们回顾了 COVID-19 的病理生理学、心血管表现以及新兴治疗前景。在这个快速发展的领域,本综述截至 2020 年 4 月 3 日是全面的。

相似文献

[1]
COVID-19 and the Heart.

Circ Res. 2020-4-7

[2]
Coronavirus disease 2019 and the cardiovascular system: Impacts and implications.

Indian Heart J. 2020

[3]
COVID-19 and Cardiovascular Disease.

Circulation. 2020-3-21

[4]
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.

Circulation. 2020-4-16

[5]
Current data on the cardiovascular effects of COVID-19.

Hellenic J Cardiol. 2020

[6]
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.

Heart Lung Circ. 2020-6-5

[7]
Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?

Pharmacol Res. 2020-9

[8]
COVID-19 and the Heart.

Arq Bras Cardiol. 2020-4

[9]
COVID-19 and the cardiovascular system.

Nat Rev Cardiol. 2020-5

[10]
Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects.

Biomed Pharmacother. 2020-9-9

引用本文的文献

[1]
Meta-analysis of mortality factors after COVID-19 infection in pediatric oncology patients.

Front Oncol. 2025-8-6

[2]
COVID-19 and Myocarditis: Trends, Clinical Characteristics, and Future Directions.

J Clin Med. 2025-6-27

[3]
Heterozygous interferon signaling deficient mice as animal models for Chikungunya virus infection in the heart.

Sci Rep. 2025-5-23

[4]
Deep insight into cytokine storm: from pathogenesis to treatment.

Signal Transduct Target Ther. 2025-4-16

[5]
Effects of COVID-19 on vital organs in patients infected with SARS-CoV-2.

GHM Open. 2021-8-31

[6]
Subtle changes on electrocardiogram in severe patients with COVID-19 may be predictors of treatment outcome.

Front Artif Intell. 2025-3-12

[7]
Cardiac structure and function 1.5 years after COVID-19: results from the EPILOC study.

Infection. 2025-2-24

[8]
Integrated Multiomics Reveals Alterations in Paucimannose and Complex Type N-Glycans in Cardiac Tissue of Patients with COVID-19.

Mol Cell Proteomics. 2025-4

[9]
Improved kidney function is associated with Colchicine treatment in COVID-19 patients.

BMC Nephrol. 2024-11-12

[10]
Impact of High Troponin Level on the Outcome in COVID-19 Positive Patients.

J Multidiscip Healthc. 2024-11-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索